Ventricular Tachycardia
📧 Sign up to get email alerts when something new happens for Ventricular Tachycardia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-09-12Clinical Trial Update: Implantable Cardioverter Defibrillator (ICD) Support Groups and Veterans
Emory University-sponsored ICD study focusing on veteran participants has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-08-28Clinical Trial Update: OMNI Study--Assessing Therapies in Medtronic Pacemaker, Defibrillator, and Cardiac Resynchronization Therapy Devices.
The OMNI Study, a Medtronic device trial evaluating therapies in pacemakers, defibrillators, and cardiac resynchronization therapy devices, …
-
FDA approval · 2013-05-31FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for amiodarone hydrochloride submitted by Chartwell RX, LLC. This marks an approval of a supplement …
-
FDA approval · 2013-05-31FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for amiodarone hydrochloride from Sun Pharmaceutical Industries, Inc., approving a change under …
-
FDA approval · 2013-05-21FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Gland Pharma Limited)
The FDA approved a supplemental application for amiodarone hydrochloride from Gland Pharma Limited, enabling its generic use.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-04-29FDA Approved: NEXTERONE — Supplemental Application (Baxter Healthcare Company)
FDA approved a supplemental application for NEXTERONE (amiodarone hydrochloride) submitted by Baxter Healthcare Company.
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: Clinical Study to Evaluate the Catheter Robotics Amigo for Performing Right-Sided Electrophysiology Mapping Studies [NA]
The clinical trial update reports completion and posting of results for a study evaluating the Amigo catheter robotics system for right-side…
-
CLINICAL_TRIALS research · 2013-01-31Clinical Trial Update: Catheter Ablation Versus Antiarrhythmic Drugs for Outflow Tract Ventricular ARrhythmias [Phase 4]
This is a Phase 4 clinical trial update comparing catheter ablation to antiarrhythmic drugs for outflow tract ventricular arrhythmias, spons…
-
CLINICAL_TRIALS trial_result · 2012-12-07Clinical Trial Update: Risk of Life-threatening Heart Rhythm Disturbances in Siblings
A completed clinical trial update discusses sibling risk for life-threatening heart rhythm disturbances in the context of implantable defibr…
-
CLINICAL_TRIALS trial_result · 2012-08-21Clinical Trial Update: DATAS: The Dual Chamber & Atrial Tachyarrhythmias Adverse Events Study [NA]
This is a completed Medtronic trial (DATAS) evaluating adverse events related to dual-chamber and atrial tachyarrhythmias in patients with i…
-
CLINICAL_TRIALS trial_result · 2012-05-08Clinical Trial Update: Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744c 100 or 300 mg for the Prevention of ventrICular ARrhythmia-triggered Icd interventiOnS [Phase 2]
Phase 2, randomized, double-blind, placebo-controlled, dose-ranging study evaluating SSR149744c at 100 mg or 300 mg for the prevention of ve…
-
CLINICAL_TRIALS safety_alert · 2012-03-21Clinical Trial Update: Safety of Amiodarone and Ranolazine Together in Patients With Angina [Phase 4]
Phase 4 clinical trial update evaluating the safety of co-administering amiodarone and ranolazine in patients with angina and related cardio…
-
FDA approval · 2012-01-11FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for sotalol hydrochloride, confirming approval of a generic product. …
-
CLINICAL_TRIALS trial_result · 2011-12-22Clinical Trial Update: Biventricular Tachycardias Outcome Trial [Phase 4]
The document reports that LivaNova's Phase 4 Biventricular Tachycardias Outcome Trial has completed. No trial results are provided in the sn…
-
FDA approval · 2011-12-12FDA Approved: NEXTERONE — Supplemental Application (Baxter Healthcare Company)
FDA approved a supplemental application for NEXTERONE (amiodarone hydrochloride) from Baxter Healthcare Company.
-
FDA approval · 2011-08-17FDA Approved: BETAPACE — Supplemental Application (Legacy Pharma USA, Inc.)
FDA approved a supplemental application for BETAPACE (sotalol hydrochloride) from Legacy Pharma USA, Inc.
-
CLINICAL_TRIALS trial_result · 2011-05-25Clinical Trial Update: Benefits of Implantable Cardioverter Defibrillator Follow-up Using Remote Monitoring [NA]
A completed clinical trial update evaluating the benefits of remote-monitoring follow-up for patients with implantable cardioverter-defibril…
-
FDA approval · 2011-04-28FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Sotalol Hydrochloride by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2011-02-03FDA Approved: BETAPACE — Supplemental Application (Legacy Pharma USA, Inc.)
FDA approved a supplemental application for BETAPACE (sotalol hydrochloride) submitted by Legacy Pharma USA, Inc., resulting in updated labe…
-
CLINICAL_TRIALS trial_result · 2011-01-17Clinical Trial Update: Remote Follow-up of Patients Receiving Implantable Cardioverter Defibrillator for Prophylactic Therapy [Phase 4]
A Phase 4 clinical trial assessing remote follow-up for patients with implantable cardioverter defibrillators for prophylactic therapy has c…
-
CLINICAL_TRIALS trial_result · 2010-12-15Clinical Trial Update: Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias [Phase 4]
A Phase 4 clinical trial evaluating ajmaline for the diagnosis and treatment of cardiac arrhythmias has completed, including assessments in …
-
CLINICAL_TRIALS research · 2010-10-18Clinical Trial Update: Accuracy and Safety Study of the Magnetecs CGCI System for Intracardiac Mapping [Phase 1, Phase 2]
This clinical trial update reports on an ongoing Phase 1/2 study evaluating the Magnetecs CGCI System for intracardiac mapping, with the cur…
-
FDA approval · 2010-08-31FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for amiodarone hydrochloride from Zydus Lifesciences Limited, authorizing the continued marketing of…
-
CLINICAL_TRIALS trial_result · 2010-05-20Clinical Trial Update: The Efficacy and Safety of CARTO 3D Mapping System Versus Conventional Method in AF and VT [Phase 4]
Phase 4 clinical trial comparing the CARTO 3D mapping system with a conventional method in atrial fibrillation and ventricular tachycardia. …
-
FDA approval · 2010-02-04FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for amiodarone hydrochloride from Sun Pharmaceutical Industries, approving the supplemental filing f…